Search results
Showing results for
David received his MB PhD qualification from of Guy’s and St Thomas’ Medical School London. He undertook an intercalated PhD studying the role of neurotrophic factors in sensory neuronal development and the generation of persistent pain. Sub-speciality training in neurology took place principally in London at the National Hospital for Neurology and Neurosurgery, King’s College Hospital and Guy’s and St Thomas’ NHS Trust.
Oxford researchers uncover how Parkinson's disease protein damages brain cells
5 August 2026
A new study reveals a key mechanism by which the protein alpha-synuclein, the hallmark of Parkinson's disease, damages neurons (brain cells) by blocking a vital cellular gateway. The results of the study, published in Nature Communications, help to explain how the disease begins and highlights a potential new target for treatment.
New Lancet review calls for urgent action to tackle the growing global threat of encephalitis
19 June 2026
The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.
Dr Ruxandra Dafinca awarded an Alzheimer’s Society Dementia Research Leader Fellowship
4 June 2026
Ruxandra Dafinca is one of 17 early career researchers awarded a fellowship in the 2025/2026 call for her project focused on frontotemporal dementia.
Two researchers from NDCN join global network to unravel the complexity of Parkinson’s disease
13 May 2026
Two scientists from NDCN, Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease.
Study shows that non-invasive ultrasound shows promise for treating Parkinson’s disease
1 May 2026
Oxford researchers have shown for the first time that ultrasound could have similar effects on brain activity in Parkinson’s sufferers as implanted deep brain stimulation (DBS) electrodes. This opens the door to new treatment approaches that could avoid surgery.
Collaboration with the Nepal Public Health Foundation (NPHF) explores maternal health and epilepsy
26 March 2026
A new study, co-led by Professor Arjune Sen and supported by Nuffield Department of Clinical Neurosciences, aims to improve understanding of the risk factors, care pathways and broader health and social impacts of epilepsy in Nepal.
Professor Chrystalina Antoniades awarded Suffrage Science Award in Life Sciences 2026
17 March 2026
The awards took place in Oxford University's Science Area to celebrate the achievements of inspiring women in the life sciences
New funding boosts Oxford research into inflammatory neuropathies
26 February 2026
To mark Rare Disease Day on 28 February, we’re highlighting the research of Professor Simon Rinaldi and Dr Nicolas Dubuisson, and celebrating a major new $600,000 grant to progress their fight against inflammatory neuropathies.
NDCN professors amongst first Group Leaders announced for new dedicated Parkinson's Research Centre
19 February 2026
Professors Laura Parkkinen and Peter Magill have been appointed to UK DRI Group Leader roles.
Oxford-Harrington Rare Disease Centre Announces 2025 Scholars
16 December 2025
Esther Becker is one of ten recipients of the 2025 Rare Disease Scholar Award, which advances promising discoveries from academic labs into clinical practice.
Oxford researchers to redefine new human-based research models of pain
11 November 2025
An interdisciplinary team led by Professor Zameel Cader is part of a major new initiative which aims to redefine human-based research models for greater understanding of disease and the acceleration of new medicines.
New Oxford-led project aims to revolutionise chronic pain treatment
17 October 2025
The University of Oxford is to lead a new six-year, £11 million project backed by the Engineering and Physical Sciences Research Council (EPSRC) which aims develop a new generation of personalised treatments capable of reducing or abolishing chronic pain.
Oxford Cancer announces 2025 CRIS Cancer Clinical Career Fellows
13 October 2025
Oxford Cancer, together with the CRIS Cancer Foundation, is delighted to announce the appointment of the 2025 CRIS Cancer Postdoctoral Clinical Fellows: Dr Rebecca Ling and Dr Casmir Turnquist
Masud Husain wins 2025 Royal Society Trivedi Book Prize
9 October 2025
The prize was awarded for 'Our Brains, Our Selves: What a Neurologist's Patients Taught Him About the Brain'
NeuroMetrology Lab advance Parkinson’s Disease research with the Opal® Wearable Sensor System
6 October 2025
A partnership with Clario focuses on advancing the use of wearable sensors to enable more precise measurement of motor symptoms and disease progression in Parkinson's.
'A community within a community' - reflections of CNS co-chairs
2 September 2025
Postdoctoral researchers Danielle Hewitt and Maddalena Comini reflect on their time as Clinical Neurosciences Society (CNS) Co-Chairs.
Exceptional Oxford researchers awarded first Royal Society Faraday Discovery Fellowships
28 August 2025
Three pioneering Oxford researchers, including Professor Timothy Behrens from NDCN, are among the first recipients of the Royal Society Faraday Discovery Fellowships, prestigious long-term awards to support exceptional mid-career research leaders in the UK. Only seven academics were selected in total from more than 600 initial applications.
Chronic pain research breakthrough identifies promising drug target
21 August 2025
A new paper published in Nature shows how, in a collaborative project across diverse medical disciplines, Oxford researchers from NDCN and the Department of Biochemistry have identified a new genetic link to pain.
Prehistoric teeth used to create historic map of infectious diseases
29 July 2025
A research project led jointly by researchers from NDCN, the University of Copenhagen and University of Cambridge shows that large-scale mapping of prehistoric teeth and bones provides new knowledge of present-day infectious diseases. This may, among other things, have an impact on the development of vaccines.